American Oriental Bioengineering, Inc. · Beijing China (NYSE: AOB)
| 1 Liangshuihe First Ave., Beijing E-Town Economic And Technology Development Area, E-Town | Phone: +86-10-5982-2039 |
| Beijing | Fax: 201-200-9928 |
| 100176 | |
| China |
American Oriental Bioengineering, Inc. Rankings
Company Description
American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 90 plant-based pharmaceuticals and nutraceuticals based on Traditional Chinese Medicine (TCM). Its products (primarily sold in China) include prescription and over-the-counter herbal and vitamin beverages, pills, gels, patches, and powders to treat a variety of ailments from bedwetting to respiratory diseases. It sells directly to retail stores, pharmacies, hospitals, and independent distributors who act as resellers. AOBO, which was founded in 1970, operates about 30 offices throughout China. CEO Tony Liu has a controlling ownership stake (about 40%) in the company.
Financials
| Company Type | Public - NYSE: AOB |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 4,295 |
Executives
10 executives listed for American Oriental Bioengineering, Inc.'s Beijing, China location.
| Chairman and CEO | Shujun Liu | |
|---|---|---|
| COO | Xiaopeng Xu | |
| CFO and Director | Yanchun Li |


